The firm will use the funds to develop a proof of concept and apply for FDA authorization.Read More
Tags :respira
The former Altria executive will lead the health technology firm into its next phase of growth.Read More
The technology represents a world first, says Respira. Read More
Quigley will help lead the next phase of growth for Respira's unique product platforms.Read More
The company says it aims to disrupt a $618 billion market dominated by decades-old gums and patches as well as electronic nicotine-delivery devices.Read More
